The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19

Clinical Trial ID NCT04273581

PubWeight™ 0.00‹?›

🔗 Visit the page for NCT04273581

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
2 The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer 2004 3.58
3 Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. Clin Exp Immunol 2009 0.76
4 Anti-inflammatory effect of thalidomide on H1N1 influenza virus-induced pulmonary injury in mice. Inflammation 2014 0.75
Next 100